Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Eternygen raises €8mm in Series A round; includes investment from partner Evotec

Executive Summary

Eternygen GMBH (metabolic disease focused biopharma) raised €8mm ($8.3mm) in its Series A financing round led by Epidarex Capital, along with VC Founds Technologie (managed by IBB Beteiligungsgesellschaft), and two family offices. The round also includes participation from partner Evotec AG.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies